Evidence map›Paper›PMID 35162696›Full record

ArticleInternational journal of environmental research and public health2022

Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare.

Denis Horgan, Bettina Borisch, Ivana Cattaneo, Mark Caulfield, Arturo Chiti, Christine Chomienne, Amanda Cole, Karen Facey, Allan Hackshaw, Minna Hendolin and 4 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Denis HorganEuropean Alliance for Personalised Medicine, 1040 Brussels, Belgium.
Bettina BorischDepartment of Histopathology, University of Geneva, 1202 Geneva, Switzerland.
Ivana CattaneoNovartis Farma SpA, 21040 Origgio, Italy.
Mark CaulfieldNIHR Barts Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK.
Arturo ChitiDepartment of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy.
Christine ChomienneCell Biology-Hematology Department, Université de Paris INSERM, 75010 Paris, France.
Amanda ColeOffice of Health Economics, London SW1E 6QT, UK.ORCID 0000-0001-6179-7752
Karen FaceyUsher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH8 9YL, UK.ORCID 0000-0001-6670-5271
Allan HackshawFaculty of Medical Sciences, University College London, London W1T 4TJ, UK.
Minna HendolinSitra-The Finnish Innovation Fund, 00180 Helsinki, Finland.
Nadia GeorgesExact Sciences, 1201 Geneva, Switzerland.
Dipak KalraFaculty of Medicine and Health Sciences, University of Ghent, 9000 Ghent, Belgium.
Birutė TumienėVilnius University Hospital Santariskiu Klinikos, 08661 Vilnius, Lithuania.
Martina von MeyennF. Hoffmann-La Roche AG, 4070 Basel, Switzerland.

Funding

Medical Research Council MC_EX_MR/M009203/1Medical Research Council MC_PC_14089Medical Research Council MR/M009203/1
6 · The paper itself

Abstract

The potential for the use of real-world data (RWD) to generate real-world evidence (RWE) that can inform clinical decision-making and health policy is increasingly recognized, albeit with hesitancy in some circles. If used appropriately, the rapidly expanding wealth of health data could improve healthcare research, delivery of care, and patient outcomes. However, this depends on two key factors: (1) building structures that increase the confidence and willingness of European Union (EU) citizens to permit the collection and use of their data, and (2) development of EU health policy to support and shape data collection infrastructures, methodologies, transmission, and use. The great potential for use of RWE in healthcare improvement merits careful exploration of the drivers of, and challenges preventing, efficient RWD curation. Literature-based research was performed to identify relevant themes and discussion topics for two sets of expert panels, organized by the European Alliance for Personalised Medicine. These expert panels discussed steps that would enable a gradual but steady growth in the quantity, quality, and beneficial deployment of RWE. Participants were selected to provide insight based on their professional medical, economic, patient, industry, or governmental experience. Here, we propose a framework that addresses public trust and access to data, cross-border governance, alignment of evidence frameworks, and demonstrable improvements in healthcare decisions. We also discuss key case studies that support these recommendations, in accordance with the discussions at the expert panels.

Indexed as

Delivery of Health CareTrustData CollectionHealth PolicyHealth Services ResearchHumanscitizen trustevidence frameworkreal-world datareal-world evidence

Identifiers

PMID35162696
PMCPMC8835047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.